US20170051344A1 - Purification Chemistries and Formats for Sanger DNA Sequencing Reactions on a Micro-Fluidics Device - Google Patents
Purification Chemistries and Formats for Sanger DNA Sequencing Reactions on a Micro-Fluidics Device Download PDFInfo
- Publication number
- US20170051344A1 US20170051344A1 US15/113,786 US201515113786A US2017051344A1 US 20170051344 A1 US20170051344 A1 US 20170051344A1 US 201515113786 A US201515113786 A US 201515113786A US 2017051344 A1 US2017051344 A1 US 2017051344A1
- Authority
- US
- United States
- Prior art keywords
- sequencing
- purification device
- microfluidic
- sequencing reaction
- reaction purification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502753—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0631—Purification arrangements, e.g. solid phase extraction [SPE]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/10—Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/14—Process control and prevention of errors
- B01L2200/141—Preventing contamination, tampering
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0887—Laminated structure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/12—Specific details about materials
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/16—Surface properties and coatings
Definitions
- DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule.
- Two common sequencing methods are Sanger sequencing and “Next-Gen” sequencing, where Sanger sequencing is a method of DNA sequencing based on the selective incorporation of chain-terminating dideoxynucleotides (or ddNTPs) by DNA polymerase during in vitro DNA replication. While “Next-Gen” sequencing methods are typically used for large-scale, automated genome analyses, Sanger sequencing is primarily used for smaller-scale projects with the goal of obtaining especially long contiguous DNA sequence reads (>500 nucleotides).
- labeled (either radioactively or fluorescently) amplification compounds modified nucleotides or ddNTPs
- ddNTPs modified nucleotides
- sequencing reaction purification or cleanup efforts generally focus on single-stranded DNA and generally requires expulsion to a high degree of the sequencing reaction contaminants, including buffering salts (de-salting), other ions, and unincorporated dye-ddNTP (dye-terminator) such that ionic strength is significantly reduced relative to the original reaction.
- buffering salts de-salting
- other ions unincorporated dye-ddNTP (dye-terminator)
- dye-ddNTP dye-terminator
- a target for residual salt level after purification could be less than or equal to 5 mM.
- a post-purification target could be greater than 1000-fold reduction from the original dye terminator concentration.
- a further need is the implementation of such a system for purification on a microfluidics chip, as known methods for purification have not been implemented on a microfluidics chip.
- a microfluidics-chip based purification device and system for Sanger-sequencing reactions is provided.
- the device and system allow for the introduction into a sequencing system of a cartridge containing purification technologies specific to the sequencing contaminants or sequencing method where the simplified purification solution of a cartridge allows automation of the sample purification process, reduced consumption of purification reagents, and consistency in sampling by reducing the sampling errors and artifacts.
- These various embodiments therefore solve the need for a microfluidics-chip-based, Sanger-sequencing reaction purification system for CE devices.
- the microfluidic chips described can be used as a PCR chip by reorganizing the on-chip reagents, reaction wells and work flow steps.
- a microfluidic sequencing reaction purification device for reducing the number of sequencing contaminants in a single-stranded DNA sequencing sample.
- the microfluidics chip-based sequencing reaction purification device can comprising a surface, a solid-phase extraction substrate and silane bound to a structure.
- the structure can be selected from the group consisting of microstructures, the surface of the microfluidic device, a membrane, a high-surface area, convoluted material, and combinations thereof.
- a microfluidic sequencing reaction purification device for reducing the number of sequencing contaminants in a single-stranded DNA sequencing sample.
- the microfluidic sequencing reaction purification device can comprise a surface and a reagent bound to a structure.
- the structure can be selected from the group consisting of microstructures, the surface of the microfluidic device, a membrane, a high-surface area, convoluted material, and combinations thereof.
- a microfluidic sequencing reaction purification system for reducing the number of sequencing contaminants in a single-stranded DNA sequencing sample and automating the purification process.
- the microfluidics chip-based sequencing reaction purification system can comprise a DNA sequencing system, a microfluidics device configured to operate within the DNA sequencing system.
- the microfluidics chip can comprise a surface and a reagent bound to a structure selected from the group consisting of a solid-phase extraction structure, microstructures, the surface of the microfluidics device, a membrane, a high-surface area, convoluted material, and combinations thereof.
- FIG. 1 illustrates sequencing data from sequence purified using ChargeSwitch® in 96 well plate.
- FIG. 2 illustrates sequencing data from sequence purified using Dynabeads® in 96 well plate.
- FIG. 3 illustrates a side view of a flow-channel according to one embodiment of the invention.
- formats are possible for the implementation of purification media on a microfluidics device. Formats include, for example, micro-beads (for example polystyrene, latex beads or ion-exchange resin), modified surface on the microfluidics device, frits and membranes composed of DNA binding material and paramagnetic beads.
- micro-beads for example polystyrene, latex beads or ion-exchange resin
- frits composed of DNA binding material and paramagnetic beads.
- Solid-phase extraction is a separation process by which compounds (solutes) dissolved or suspended in a liquid mixture are separated from other compounds in the mixture according to their physical and chemical properties by using the affinity of the solutes for a solid through which the sample is passed to separate the mixture into distinct components.
- the microfluidics-chip-based purification device is a solid phase extraction cartridge utilizing silane bound to microbeads, membranes, or microstructures within the device (e.g., plastic tubes or plates).
- the microfluidics device and silane-coated microbeads is utilized in combination as a Sanger sequencing reaction purification system.
- the silane-coated microbreads may comprise polystyrene, latex, agarose, an ion-exchange resin, an immobilized metal affinity chromatography (IMAC) resin, or any other substrate or resin capable of being coated by silane and utilized in a Sanger sequencing reaction purification system.
- the microstructures may be non-magnetic, magnetic, or paramagnetic.
- the silane is bound to a structure including, but not limited to, a frit, a wool, a membrane or any other high-surface area, convoluted material, structure, or compound capable of being incorporated into a microfluidics device.
- the microfluidics device can be, for example, a microfluidic chip, card or cartridge.
- silane-coated microbeads bind single stranded DNA (ssDNA) and RNA.
- DNA can be bound in very low copy numbers. For example, as little as 10 copies of M13 single-stranded DNA could be captured and eluted from the paramagnetic beads.
- 2 mg are used in a 400 ⁇ l bind reaction volume to capture approximately 5 ⁇ g of genomic double stranded DNA onto the surface of the paramagnetic micro beads.
- the conditions chosen for these experiments were such that the standard (tube)-scale amounts of beads (2 mg per assay) were used to extract the ssDNA in a 400 ⁇ l volume.
- the beads are paramagnetic, they can be easily immobilized in a microfluidic device (e.g., cartridge) format.
- Reversible ion-exchange binding of DNA is a purification, separation, or decontamination process by which ions are exchanged between two electrolytes or between an electrolyte solution and a complex.
- the process typically involves solid polymeric or mineralic ion exchangers (e.g., ion exchange resins (such as functionalized porous or gel polymers), zeolites, and montmorillonite, clay, or soil humus).
- Ion exchangers can also include, for example, ionizable (or switchable) ion exchangers.
- the ion-exchanger comprises a surface ligand whose surface charge is a function of pH.
- the ion-exchanger surface ligand for example, can be positively charged at low pH, and neutral at pH 8.5, to bind and elute plasmid.
- a microfluidics device comprising microstructures (such as microbeads, tubes, or plates) coated in at least one ion-exchanger is utilized as a Sanger sequencing reaction purification system.
- the surface of the microfluidics device can be coated in at least one ion-exchanger.
- the microfluidics device can comprise a membrane coated with at least one ion-exchanger.
- the ion-exchanger can be bound to a structure including, but not limited to, a frit, a wool, a membrane or any other high-surface area, convoluted material, structure, or compound capable of being incorporated into a microfluidics device.
- microstructures In a further example, one or any combination of the microstructures, the device surface, a high-surface area structure, or a membrane can be coated in an ion-exchanger as described above.
- the microstructures may be, for example, non-magnetic, magnetic, or paramagnetic.
- the microfluidics device can be, for example, a microfluidic chip, card or cartridge.
- Size exclusion and ion-exchange is a process in which molecules in solution are separated by their size (e.g., molecular weight) and charge.
- a Sanger sequencing reaction purification system utilizes a microfluidics device and reagents specifically chosen to sequester reaction components based on the components charge and size. These reagents can be utilized by the microfluidics device to capture unincorporated dye exterminators, dNTPs, free salts, or salt ions generated during the sequencing reaction.
- the reagents can be bound to microstructures, where the microstructures may comprise microbeads, membranes, or structures within the chip (e.g., plastic tubes or plates).
- the reagents can be bound to microstructures (such as microbeads, tubes, plates, or any combination of these structures) that may be, for example, non-magnetic, magnetic, or paramagnetic.
- the reagents can be bound to the surface of the microfluidics device, or can also be bound to a structure including, but not limited to, a frit, a wool, a membrane or any other high-surface area, convoluted material, structure, or compound capable of being incorporated into a microfluidics device.
- the size-exclusion and ion-exchange reagents can be bound to one or any combination of microstructures, the surface of the microfluidics device, or a high-surface area, convoluted structure within the microfluidics device as described above.
- the microfluidics device can be, for example, a microfluidic chip, card or cartridge.
- size exclusion beads work by binding the known impurities.
- Sephadex® beads for example are very cost-effective commercially available size exclusion beads that have the ability to extract terminators and salt while leaving the products of the sequencing reaction in solution. These beads advantageously have a relatively low cost. Moreover, they have been used routinely for sequencing reaction cleanup in conjunction with 96-well filter plates (for example, MultiScreen® 96w plates (Durapore® or Ultracell®-10 filter) from Millipore).
- Purification by membrane is a mechanical separation process in which undesirable sequencing solution reaction compounds are removed from the system using binding buffers and a porous physical structure (such as a membrane) through which the bound reaction compounds cannot pass.
- the system uses at least one binding buffer and at least one porous structure configured to remove reaction compounds such as short primers, dNTPs, enzymes, short-failed PCR/CE products, salts from PCR/CE products, or any combination thereof.
- a Sanger sequencing reaction purification system utilizes a microfluidics device comprising at least one binding buffer and at least one membrane.
- the membrane may be any structure including, but not limited to, a frit, a wool, a membrane, or any porous, high-surface structure through which a solution may pass.
- the microfluidics device can be, for example, a microfluidic chip, card or cartridge.
- An example of purification by membrane is PureLink®, manufactured by Life Technologies.
- Hybridization-based pull-out is based on hybridization-binding of the sequencing reaction products to a complementary oligonucleotide that is attached or bound to a microstructure or the surface of the microfluidics device.
- a Sanger sequencing reaction purification system utilizes a microfluidics device comprising at least one hybridization-based pull-out oligonucleotide selected to be complementary to a sequencing reaction product.
- the hybridization-based pull-out oligonucleotide is bound to a microstructure or the surface of the microfluidics device.
- the microstructures may be, for example, non-magnetic, magnetic, or paramagnetic.
- the hybridization-based pull-out oligonucleotide can be bound to a structure including, but not limited to, a frit, a wool, a membrane or any other high-surface area, convoluted material, structure, or compound capable of being incorporated into a microfluidics device.
- the hybridization-based pull-out oligonucleotide can also be bound to one or any combination of microstructures, the surface of the microfluidics device, or a high-surface-area, convoluted structure as described above.
- the microfluidics device can be, for example, a microfluidic chip, card or cartridge.
- Hybridization beads for example, with capturing oligonucleotide attached to its surface, can be made by numerous manufacturing processes including, for example, the process used to manufacture Anti-miRNA Bead Capture (ABC) beads.
- the ABC kit is a commercialized product for capturing specific miRNA from a biological sample (e.g., blood) directly. It can use a complementary oligonucleotide on a magnetic bead to hybridized and capture specific miRNA.
- the bead-oligo linkage is covalent and permanent using the well-known carboxy (on bead), NH-ester (on oligo) standard chemistry.
- the microfluidics device comprises multiple technologies, including, but not limited to, solid-phase extraction technology utilizing silane, reversible ion exchange binding of DNA, size exclusion and ion-exchange technology, membrane technology, and hybridization-based pull-out technology.
- Bis-Tris is reacted with Polyacrylic Acid in the presence of EDC to yield a polymer containing bound Bis-Tris.
- FIG. 1 illustrates sequencing data from sequence purified using ChargeSwitch® in 96 well plate.
- Dynabeads® MyOneTM SILANE (product of Life Technologies) are supplied at a concentration of 40 mg/ml. Prior to use, the beads should be transferred to the appropriate binding solution as follows:
- FIG. 2 illustrates sequencing data from sequence purified using Dynabeads® in 96 well plate.
- BigDye XTerminator® example of SEIE purification. BigDye XTerminator® (BDX) (product of Life Technologies) is used for sequencing purification in 96 or 384 well-based plates. BDX beads capture the left over waste products from the BDX reactions.
- the BDX beads are two bead types. The first is an ion exchange bead designed to capture negative charged items. These beads are also coated with a surface that will prevent large negative charged sample fragments from binding.
- the second bead-type is an ion exchange bead that captures positive charged moieties.
Abstract
Description
- DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. Two common sequencing methods are Sanger sequencing and “Next-Gen” sequencing, where Sanger sequencing is a method of DNA sequencing based on the selective incorporation of chain-terminating dideoxynucleotides (or ddNTPs) by DNA polymerase during in vitro DNA replication. While “Next-Gen” sequencing methods are typically used for large-scale, automated genome analyses, Sanger sequencing is primarily used for smaller-scale projects with the goal of obtaining especially long contiguous DNA sequence reads (>500 nucleotides). The use of labeled (either radioactively or fluorescently) amplification compounds (modified nucleotides or ddNTPs) for detection in automated sequencing machines typically results in contamination of subsequent sequences if the systems are not properly decontaminated and cleaned. Because avoidance of any overlap in amplification compound detection requires precise adjustment of all amplification products, the cleanup of, for example, fluorescence-based Sanger sequencing reactions is a crucial sample preparation step before subsequent sample analysis. In the context of other DNA purification methods, sequencing reaction purification or cleanup efforts generally focus on single-stranded DNA and generally requires expulsion to a high degree of the sequencing reaction contaminants, including buffering salts (de-salting), other ions, and unincorporated dye-ddNTP (dye-terminator) such that ionic strength is significantly reduced relative to the original reaction. For example, a target for residual salt level after purification could be less than or equal to 5 mM. Further, for dye terminators, a post-purification target could be greater than 1000-fold reduction from the original dye terminator concentration.
- As a result, what is needed is a system to automate and simplify the generation of a clean sequencing sample that, except for the potential addition of certain compounds (such as formamide) and certain processes (such as heat-denaturation), yields a sequencing solution with low contaminant concentrations and is ready for electrokinetic injection and electrophoretic separation by capillary electrophoresis (CE).
- A further need, for reasons discussed below, is the implementation of such a system for purification on a microfluidics chip, as known methods for purification have not been implemented on a microfluidics chip.
- Purification of double-stranded DNA on microfluidics chips (for example, during the extraction and purification of biological samples such as whole blood or the clean up of PCR-products) have been largely described in the literature. However, only a limited amount of research has been devoted to systems allowing on-chip purification of Sanger sequencing single-stranded DNA reactions because sequencing is a very demanding application to integrate on a microchip, by requiring two rounds of thermocycling, with each requiring subsequent cleanup. Most published DNA assay chips (e.g., Rheonix Card®) are more modest in scope, implementing simpler workflows, or performing simple 1- or 2-step protocols like the gDNA preparation or one thermocycling PCR reaction alone.
- One of the few publications demonstrating a microfluidics-based Sanger sequencing reaction cleanup (Mathies group of Blazej, Kumaresan and Mathies) describes an affinity capture/electro-elution chip functionality for the purpose of sequencing reaction clean-up. In particular, universal capture oligonucleotides covalently attached to the surface of a gel matrix ‘capture gel’ (created in one area of the chip) hybridize the sequencing products. Although this system allows for removal of charged impurities such as excess dye-terminator and salt by electrophoretic-elution, the sequencing reaction cleanup method requires the chip to be electrically connected and able to perform electrophoresis to function.
- According to various embodiments described herein, a microfluidics-chip based purification device and system for Sanger-sequencing reactions is provided. The device and system allow for the introduction into a sequencing system of a cartridge containing purification technologies specific to the sequencing contaminants or sequencing method where the simplified purification solution of a cartridge allows automation of the sample purification process, reduced consumption of purification reagents, and consistency in sampling by reducing the sampling errors and artifacts. These various embodiments therefore solve the need for a microfluidics-chip-based, Sanger-sequencing reaction purification system for CE devices. Though the following focuses on Sanger-sequencing reaction purification systems for CE, the microfluidic chips described can be used as a PCR chip by reorganizing the on-chip reagents, reaction wells and work flow steps.
- In an embodiment, a microfluidic sequencing reaction purification device is provided for reducing the number of sequencing contaminants in a single-stranded DNA sequencing sample. The microfluidics chip-based sequencing reaction purification device can comprising a surface, a solid-phase extraction substrate and silane bound to a structure. The structure can be selected from the group consisting of microstructures, the surface of the microfluidic device, a membrane, a high-surface area, convoluted material, and combinations thereof.
- In another embodiment, a microfluidic sequencing reaction purification device is provided for reducing the number of sequencing contaminants in a single-stranded DNA sequencing sample. The microfluidic sequencing reaction purification device can comprise a surface and a reagent bound to a structure. The structure can be selected from the group consisting of microstructures, the surface of the microfluidic device, a membrane, a high-surface area, convoluted material, and combinations thereof.
- In a further embodiment, a microfluidic sequencing reaction purification system is provided for reducing the number of sequencing contaminants in a single-stranded DNA sequencing sample and automating the purification process. The microfluidics chip-based sequencing reaction purification system can comprise a DNA sequencing system, a microfluidics device configured to operate within the DNA sequencing system. The microfluidics chip can comprise a surface and a reagent bound to a structure selected from the group consisting of a solid-phase extraction structure, microstructures, the surface of the microfluidics device, a membrane, a high-surface area, convoluted material, and combinations thereof.
-
FIG. 1 illustrates sequencing data from sequence purified using ChargeSwitch® in 96 well plate. -
FIG. 2 illustrates sequencing data from sequence purified using Dynabeads® in 96 well plate. -
FIG. 3 illustrates a side view of a flow-channel according to one embodiment of the invention. - The following description provides embodiments of the present invention. Such description is not intended to limit the scope of the present invention, but merely to provide a description of embodiments.
- Several formats are possible for the implementation of purification media on a microfluidics device. Formats include, for example, micro-beads (for example polystyrene, latex beads or ion-exchange resin), modified surface on the microfluidics device, frits and membranes composed of DNA binding material and paramagnetic beads.
- Combinations of non-limiting examples of purification methods and formats are summarized in the following table. Selection can be based on commercial availability, ease of implementation on a microfluidics device and least required R&D development effort.
-
Surface coating (Non- Para- of the magnetic) magnetic micro Frit or micro micro fluidics wool Chemistry/Format beads beads device Membrane material Silane X ChargeSwitch ® X X BDX ® X PureLink ® X Hybridization X based pull-out Size Exclusion X - Each of these exemplary formats are discussed below in relation to exemplary purifications chemistries.
- Solid-phase extraction (SPE) is a separation process by which compounds (solutes) dissolved or suspended in a liquid mixture are separated from other compounds in the mixture according to their physical and chemical properties by using the affinity of the solutes for a solid through which the sample is passed to separate the mixture into distinct components. In one embodiment, the microfluidics-chip-based purification device is a solid phase extraction cartridge utilizing silane bound to microbeads, membranes, or microstructures within the device (e.g., plastic tubes or plates). In one embodiment, the microfluidics device and silane-coated microbeads is utilized in combination as a Sanger sequencing reaction purification system. In alternative embodiments, the silane-coated microbreads may comprise polystyrene, latex, agarose, an ion-exchange resin, an immobilized metal affinity chromatography (IMAC) resin, or any other substrate or resin capable of being coated by silane and utilized in a Sanger sequencing reaction purification system. In yet another embodiment of the purification system utilizing silane-coated microstructures (such as microbeads, tubes, plates, or any combination of these structures), the microstructures may be non-magnetic, magnetic, or paramagnetic. In yet another embodiment, the silane is bound to a structure including, but not limited to, a frit, a wool, a membrane or any other high-surface area, convoluted material, structure, or compound capable of being incorporated into a microfluidics device. The microfluidics device can be, for example, a microfluidic chip, card or cartridge.
- In an embodiment, silane-coated microbeads (e.g., paramagnetic beads) bind single stranded DNA (ssDNA) and RNA. DNA can be bound in very low copy numbers. For example, as little as 10 copies of M13 single-stranded DNA could be captured and eluted from the paramagnetic beads. In a typical silane-coated bead purification protocol, 2 mg are used in a 400 μl bind reaction volume to capture approximately 5 μg of genomic double stranded DNA onto the surface of the paramagnetic micro beads. The conditions chosen for these experiments were such that the standard (tube)-scale amounts of beads (2 mg per assay) were used to extract the ssDNA in a 400 μl volume. Moreover, since the beads are paramagnetic, they can be easily immobilized in a microfluidic device (e.g., cartridge) format.
- Reversible ion-exchange binding of DNA is a purification, separation, or decontamination process by which ions are exchanged between two electrolytes or between an electrolyte solution and a complex. The process typically involves solid polymeric or mineralic ion exchangers (e.g., ion exchange resins (such as functionalized porous or gel polymers), zeolites, and montmorillonite, clay, or soil humus). Ion exchangers can also include, for example, ionizable (or switchable) ion exchangers. In an embodiment of an ion-exchanger, the ion-exchanger comprises a surface ligand whose surface charge is a function of pH. The ion-exchanger surface ligand, for example, can be positively charged at low pH, and neutral at pH 8.5, to bind and elute plasmid.
- In an alternative embodiment of the purification system, a microfluidics device comprising microstructures (such as microbeads, tubes, or plates) coated in at least one ion-exchanger is utilized as a Sanger sequencing reaction purification system. For example, the surface of the microfluidics device can be coated in at least one ion-exchanger. In another example, the microfluidics device can comprise a membrane coated with at least one ion-exchanger. In yet another example, the ion-exchanger can be bound to a structure including, but not limited to, a frit, a wool, a membrane or any other high-surface area, convoluted material, structure, or compound capable of being incorporated into a microfluidics device. In a further example, one or any combination of the microstructures, the device surface, a high-surface area structure, or a membrane can be coated in an ion-exchanger as described above. In another embodiment of the purification system utilizing ion-exchanger-coated microstructures (such as microbeads, tubes, plates, or any combination of these structures), the microstructures may be, for example, non-magnetic, magnetic, or paramagnetic. The microfluidics device can be, for example, a microfluidic chip, card or cartridge.
- Size exclusion and ion-exchange (SEIE) is a process in which molecules in solution are separated by their size (e.g., molecular weight) and charge. In an alternative embodiment of the purification system, a Sanger sequencing reaction purification system utilizes a microfluidics device and reagents specifically chosen to sequester reaction components based on the components charge and size. These reagents can be utilized by the microfluidics device to capture unincorporated dye exterminators, dNTPs, free salts, or salt ions generated during the sequencing reaction. The reagents can be bound to microstructures, where the microstructures may comprise microbeads, membranes, or structures within the chip (e.g., plastic tubes or plates). The reagents can be bound to microstructures (such as microbeads, tubes, plates, or any combination of these structures) that may be, for example, non-magnetic, magnetic, or paramagnetic. Alternatively, the reagents can be bound to the surface of the microfluidics device, or can also be bound to a structure including, but not limited to, a frit, a wool, a membrane or any other high-surface area, convoluted material, structure, or compound capable of being incorporated into a microfluidics device. Finally, the size-exclusion and ion-exchange reagents can be bound to one or any combination of microstructures, the surface of the microfluidics device, or a high-surface area, convoluted structure within the microfluidics device as described above. The microfluidics device can be, for example, a microfluidic chip, card or cartridge.
- In contrast to other cleanup chemistry (bind-wash-elute style), size exclusion beads work by binding the known impurities. Sephadex® beads, for example are very cost-effective commercially available size exclusion beads that have the ability to extract terminators and salt while leaving the products of the sequencing reaction in solution. These beads advantageously have a relatively low cost. Moreover, they have been used routinely for sequencing reaction cleanup in conjunction with 96-well filter plates (for example, MultiScreen® 96w plates (Durapore® or Ultracell®-10 filter) from Millipore).
- Purification by membrane is a mechanical separation process in which undesirable sequencing solution reaction compounds are removed from the system using binding buffers and a porous physical structure (such as a membrane) through which the bound reaction compounds cannot pass. In one embodiment, the system uses at least one binding buffer and at least one porous structure configured to remove reaction compounds such as short primers, dNTPs, enzymes, short-failed PCR/CE products, salts from PCR/CE products, or any combination thereof. In an alternative embodiment of the purification system, a Sanger sequencing reaction purification system utilizes a microfluidics device comprising at least one binding buffer and at least one membrane. The membrane may be any structure including, but not limited to, a frit, a wool, a membrane, or any porous, high-surface structure through which a solution may pass. The microfluidics device can be, for example, a microfluidic chip, card or cartridge. An example of purification by membrane is PureLink®, manufactured by Life Technologies.
- Hybridization-based pull-out is based on hybridization-binding of the sequencing reaction products to a complementary oligonucleotide that is attached or bound to a microstructure or the surface of the microfluidics device. In an embodiment of the purification system, a Sanger sequencing reaction purification system utilizes a microfluidics device comprising at least one hybridization-based pull-out oligonucleotide selected to be complementary to a sequencing reaction product. In an alternative embodiment, the hybridization-based pull-out oligonucleotide is bound to a microstructure or the surface of the microfluidics device. In another embodiment of the purification system utilizing hybridization-based pull-out oligonucleotides bound to microstructures (such as microbeads, tubes, plates, or any combination of these structures), the microstructures may be, for example, non-magnetic, magnetic, or paramagnetic. The hybridization-based pull-out oligonucleotide can be bound to a structure including, but not limited to, a frit, a wool, a membrane or any other high-surface area, convoluted material, structure, or compound capable of being incorporated into a microfluidics device. The hybridization-based pull-out oligonucleotide can also be bound to one or any combination of microstructures, the surface of the microfluidics device, or a high-surface-area, convoluted structure as described above. The microfluidics device can be, for example, a microfluidic chip, card or cartridge.
- Hybridization beads, for example, with capturing oligonucleotide attached to its surface, can be made by numerous manufacturing processes including, for example, the process used to manufacture Anti-miRNA Bead Capture (ABC) beads. The ABC kit is a commercialized product for capturing specific miRNA from a biological sample (e.g., blood) directly. It can use a complementary oligonucleotide on a magnetic bead to hybridized and capture specific miRNA. The bead-oligo linkage is covalent and permanent using the well-known carboxy (on bead), NH-ester (on oligo) standard chemistry.
- In another embodiment, the microfluidics device comprises multiple technologies, including, but not limited to, solid-phase extraction technology utilizing silane, reversible ion exchange binding of DNA, size exclusion and ion-exchange technology, membrane technology, and hybridization-based pull-out technology.
- ChargeSwitch® (product of Life Technologies) Purification example of reversible IE binding of DNA:
- Bis-Tris is reacted with Polyacrylic Acid in the presence of EDC to yield a polymer containing bound Bis-Tris.
-
- Polymer bound Bis-Tris can be protonated by acid (H+) in acidic conditions producing a positive charged surface. The positively charged polymer selectively binds to DNA.
- At higher pH (>8), the polymer should still be water soluble and have no charge; effectively enabling elution of bound DNA
-
-
- 1. Polymer can be diluted in 1% PB buffer.
- 2. 100 μl of 10-100% polymer is added to the solid surface to be coated.
- 3. Wait 15 min and discard polymer from the surface
- 4. Add 100 μl of 1% PB buffer, wait 2 min and remove the buffer
- 5. Step 4 is repeated again
- 6. Air dry solid surface for at least 2 hours
- a. With polymer coated on solid surface.
-
- 1. Add 10 μl of sample to the coated surface.
- 2. Bind the sample by adding and equivalent volume (10 μl) of DCB to it.
- 3. Incubate for 15 min, remove the liquid completely.
- 4. Wash the sample by adding 150 μl of DCBW to the plate location
- 5. Incubate for 1 min, remove the liquid completely
- 6. A final wash of sample is done by flowing 150-200 μl of nuclease-free-water over the surface
- (If possible, minimize the time from adding the water to removing it in step 11 as much as possible to prevent possible elution of the bound sample.)
- 7. Elute the sample by adding 10 μl of HDF or Tris HCl (pH 8.5)
- 8. Incubate for 5 min and then collect the supernatant
- b. With polymer coated on magnetic beads.
-
- 1. To 10 μl of sample, add 10 μl DCB42 buffer and 2 μl of beads (stable at RT)
- 2. Mix and incubate at RT for 7 min
- 3. Magnetize beads and discard supernatant
- 4. Demagnetize and add 150 μl of DCBW6 wash buffer and mix
- 5. Magnetize beads and discard supernatant
- 6. Repeat step 4 & 5
- 7. Demagnetize and add 10 μl of elution buffer
- 8. Mix and incubate for 5 min
- 9. Magnetize beads and collect supernatant to sample outlet
-
FIG. 1 illustrates sequencing data from sequence purified using ChargeSwitch® in 96 well plate. - DynaBeads® Purification example of SPE:
- Dynabeads® MyOne™ SILANE (product of Life Technologies) are supplied at a concentration of 40 mg/ml. Prior to use, the beads should be transferred to the appropriate binding solution as follows:
-
- 1. Re-suspend the Dynabeads® MyOne™ SILANE completely (e.g. vortex) to a homogenous suspension prior to use. Leave on a roller until use.
- 2.
Transfer 400 μl of re-suspended Dynabeads® MyOne™ SILANE to a fresh tube. Place the tube on the magnet until the supernatant is clear, then remove and discard the supernatant. - 3. Re-suspend in 13.33 μl of 40% TEG (tetraethlyene glycol)
- 4. Add 240
μl 100% ethanol and mix thoroughly. - 5. The final bead-solution used in the isolation protocol described below should contain Dynabeads® MyOne™ SILANE at 1.5 mg/ml in 2% TEG/90% ethanol.
-
-
- 6. Add 20 μl (30 μg) Dynabeads® MyOne™ SILANE (supplied in TEG and ethanol, see above) to 10 μl sequencing reaction mix.
- 7. Mix and incubate for 10 minutes at room temperature.
- 8. Magnetize the beads and remove the supernatant completely.
- 9. Demagnetize and re-suspend the Dynabead® MyOne™ SILANE in 30
μl 55% ethanol. - 10. Magnetize the beads and remove the supernatant completely.
- 11. While still on the magnet, let the Dynabeads® MyOne™ SILANE pellet air-dry for 5 minutes at room temperature.
- 12. Demagnetize and re-suspend the Dynabeads® MyOne™ SILANE in 10 μl water.
- 13. Incubate for 3 minutes at room temperature.
- 14. Magnetize beads again and transfer the supernatant containing the sequencing products for sequencing readout.
-
FIG. 2 illustrates sequencing data from sequence purified using Dynabeads® in 96 well plate. - BigDye XTerminator® example of SEIE purification. BigDye XTerminator® (BDX) (product of Life Technologies) is used for sequencing purification in 96 or 384 well-based plates. BDX beads capture the left over waste products from the BDX reactions. The BDX beads are two bead types. The first is an ion exchange bead designed to capture negative charged items. These beads are also coated with a surface that will prevent large negative charged sample fragments from binding. The second bead-type is an ion exchange bead that captures positive charged moieties.
-
-
- 1. Add 45 μl of SAM solution and 5 μl of beads solution to 10 μl of sample at RT
- 2. Mix the liquid (by moving back and forth or as appropriate) for 20 min
- 3. The supernatant containing the sequencing reaction can be separated from beads using various methods:
- a. Magnetization can be used if BDX beads are coated on magnetic core
- b. Micro pore filters can be used to retain the beads.
- c. A flow-
channel 10 can be designed to retain beads when liquid passes through it, as illustrated inFIG. 3 .Inlet 20 accepts a mix of beads and liquid with trappedbeads 30 allowingclear liquid 40 to pass through the channel.- a. The beads can be staged such that the first beads capture the positive charged moieties and the second stage captures the negative charged moieties. The BDX beads also have a size exclusion coating that prevents the longer DNA sample fragments from being captured. The beads can be staged so that the sample does not become clogged. This may require multiple stages of beads.
- d. Mixing can be used to promote efficient waste capture in the beads. Magnetic beads can aid mixing. The beads can transit between multiple chambers or regions in single chamber with magnets that oscillate between positions.
- e. If beads are captured in a frit then the sample can oscillate back and forth in the beads. Alternatively, a fluid path could be created where the sample is circulated through bead region. After a given number of passes, a valve is opened and the clean sample is allowed to pass to the next stage.
- f. The beads and sample can be heated to increase the reaction rate of the waste to the beads. Heating can also help when charge switch or silane beads are used.
- g. Membranes with the same ion exchange and size exclusion properties can replace the BDX beads. One membrane would capture negative ions and a second the positive ions. Mixing would be achieved as for beads in a frit.
- 4. Collect the liquid for sequencing readout.
- The preceding descriptions of various implementations of the present teachings have been presented for purposes of illustration and description. It is not exhaustive and does not limit the present teachings to the precise form disclosed. Modifications and variations are possible in light of the above teachings or may be acquired from practicing of the present teachings. Additionally, the described implementation includes software but the present teachings may be implemented as a combination of hardware and software or in hardware alone. The present teachings may be implemented with both object-oriented and non-object-oriented programming systems.
Claims (23)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/113,786 US20170051344A1 (en) | 2014-01-24 | 2015-01-23 | Purification Chemistries and Formats for Sanger DNA Sequencing Reactions on a Micro-Fluidics Device |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461931549P | 2014-01-24 | 2014-01-24 | |
PCT/US2015/012777 WO2015112914A1 (en) | 2014-01-24 | 2015-01-23 | Purification chemistries and formats for sanger dna sequencing reactions on a micro-fluidics device |
US15/113,786 US20170051344A1 (en) | 2014-01-24 | 2015-01-23 | Purification Chemistries and Formats for Sanger DNA Sequencing Reactions on a Micro-Fluidics Device |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2015/012777 A-371-Of-International WO2015112914A1 (en) | 2014-01-24 | 2015-01-23 | Purification chemistries and formats for sanger dna sequencing reactions on a micro-fluidics device |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/193,232 Continuation US11905557B2 (en) | 2014-01-24 | 2021-03-05 | Purification chemistries and formats for Sanger DNA sequencing reactions on a micro-fluidics device |
Publications (1)
Publication Number | Publication Date |
---|---|
US20170051344A1 true US20170051344A1 (en) | 2017-02-23 |
Family
ID=52463184
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/113,786 Abandoned US20170051344A1 (en) | 2014-01-24 | 2015-01-23 | Purification Chemistries and Formats for Sanger DNA Sequencing Reactions on a Micro-Fluidics Device |
US17/193,232 Active 2035-10-29 US11905557B2 (en) | 2014-01-24 | 2021-03-05 | Purification chemistries and formats for Sanger DNA sequencing reactions on a micro-fluidics device |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/193,232 Active 2035-10-29 US11905557B2 (en) | 2014-01-24 | 2021-03-05 | Purification chemistries and formats for Sanger DNA sequencing reactions on a micro-fluidics device |
Country Status (2)
Country | Link |
---|---|
US (2) | US20170051344A1 (en) |
WO (1) | WO2015112914A1 (en) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020162804A1 (en) * | 2001-03-01 | 2002-11-07 | Kannan Srinivasan | Suppressed chromatography and salt conversion system |
US20040016702A1 (en) * | 2002-07-26 | 2004-01-29 | Applera Corporation | Device and method for purification of nucleic acids |
US20040209258A1 (en) * | 2003-04-17 | 2004-10-21 | 3M Innovative Properties Company | Methods and devices for removal of organic molecules from biological mixtures using an anion exchange material that includes a polyoxyalkylene |
US20050106740A1 (en) * | 2003-11-13 | 2005-05-19 | Boyes Barry E. | Methods, systems and devices for performing analytical protocols |
US20050133371A1 (en) * | 2003-09-30 | 2005-06-23 | West Virginia University Research Corporation | Apparatus and method for Edman degradation on a microfluidic device utilizing an electroosmotic flow pump |
US20080124721A1 (en) * | 2006-06-14 | 2008-05-29 | Martin Fuchs | Analysis of rare cell-enriched samples |
US20120292244A1 (en) * | 2004-02-18 | 2012-11-22 | Applied Biosystems, Llc | Polyelectrolyte-coated size-exclusion ion-exchange particles |
US20120329142A1 (en) * | 2006-03-15 | 2012-12-27 | Micronics, Inc. | Integrated nucleic acid assays |
US20160084769A1 (en) * | 2013-04-19 | 2016-03-24 | National University Of Singapore | Fluorescent Caffeine Sensor And Portable Kit And Microfluidics Device For Caffeine Detection |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5846727A (en) * | 1996-06-06 | 1998-12-08 | Board Of Supervisors Of Louisiana State University And Agricultural & Mechanical College | Microsystem for rapid DNA sequencing |
US6240790B1 (en) * | 1998-11-09 | 2001-06-05 | Agilent Technologies, Inc. | Device for high throughout sample processing, analysis and collection, and methods of use thereof |
US6541608B1 (en) | 1999-02-23 | 2003-04-01 | Baylor College Of Medicine | T cell receptor Vβ-Dβ-Jβ sequence and methods for its detection |
US6414136B1 (en) * | 1999-10-06 | 2002-07-02 | Prolinx, Inc. | Removal of dye-labeled dideoxy terminators from DNA sequencing reactions |
WO2002044414A2 (en) * | 2000-11-28 | 2002-06-06 | Promega Corporation | Purification of dna sequencing reactions using silica magnetic particles |
US7347976B2 (en) * | 2001-12-20 | 2008-03-25 | 3M Innovative Properties Company | Methods and devices for removal of organic molecules from biological mixtures using a hydrophilic solid support in a hydrophobic matrix |
US20050072674A1 (en) * | 2003-10-03 | 2005-04-07 | Agencourt Bioscience Corporation | Method and device for introducing a sample into an electrophoretic apparatus |
US7799553B2 (en) * | 2004-06-01 | 2010-09-21 | The Regents Of The University Of California | Microfabricated integrated DNA analysis system |
US9933399B2 (en) | 2012-08-31 | 2018-04-03 | Waters Technologies Corporation | Separation efficiency in supercritical fluid chromatography |
-
2015
- 2015-01-23 WO PCT/US2015/012777 patent/WO2015112914A1/en active Application Filing
- 2015-01-23 US US15/113,786 patent/US20170051344A1/en not_active Abandoned
-
2021
- 2021-03-05 US US17/193,232 patent/US11905557B2/en active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020162804A1 (en) * | 2001-03-01 | 2002-11-07 | Kannan Srinivasan | Suppressed chromatography and salt conversion system |
US20040016702A1 (en) * | 2002-07-26 | 2004-01-29 | Applera Corporation | Device and method for purification of nucleic acids |
US20040209258A1 (en) * | 2003-04-17 | 2004-10-21 | 3M Innovative Properties Company | Methods and devices for removal of organic molecules from biological mixtures using an anion exchange material that includes a polyoxyalkylene |
US20050133371A1 (en) * | 2003-09-30 | 2005-06-23 | West Virginia University Research Corporation | Apparatus and method for Edman degradation on a microfluidic device utilizing an electroosmotic flow pump |
US20050106740A1 (en) * | 2003-11-13 | 2005-05-19 | Boyes Barry E. | Methods, systems and devices for performing analytical protocols |
US20120292244A1 (en) * | 2004-02-18 | 2012-11-22 | Applied Biosystems, Llc | Polyelectrolyte-coated size-exclusion ion-exchange particles |
US20120329142A1 (en) * | 2006-03-15 | 2012-12-27 | Micronics, Inc. | Integrated nucleic acid assays |
US20080124721A1 (en) * | 2006-06-14 | 2008-05-29 | Martin Fuchs | Analysis of rare cell-enriched samples |
US20160084769A1 (en) * | 2013-04-19 | 2016-03-24 | National University Of Singapore | Fluorescent Caffeine Sensor And Portable Kit And Microfluidics Device For Caffeine Detection |
Also Published As
Publication number | Publication date |
---|---|
US20210269871A1 (en) | 2021-09-02 |
US11905557B2 (en) | 2024-02-20 |
WO2015112914A1 (en) | 2015-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10954507B2 (en) | Method for isolating RNA with high yield | |
US9624252B2 (en) | Selective nucleic acid fragment recovery | |
US9944922B2 (en) | Highly simplified lateral flow-based nucleic acid sample preparation and passive fluid flow control | |
Berensmeier | Magnetic particles for the separation and purification of nucleic acids | |
Reinholt et al. | Microfluidic isolation of nucleic acids | |
US20090215124A1 (en) | Nucleic acid isolation methods and materials and devices thereof | |
EP1892295B1 (en) | Method and device of isolating and amplifying nucleic acid from microorganism cell using nonplanar solid substrate | |
JP2008054660A (en) | Filter device for isolating nucleic acid | |
JP2007275059A (en) | Method and apparatus for refining nucleic acid | |
US11746372B2 (en) | Rapid nucleic acids separation and sample preparation via hollow-centered silica microsphere | |
JP6113083B2 (en) | Nucleic acid purification method based on microfluidic device | |
JP2007509620A (en) | Rapid and low cost nucleic acid isolation method | |
EP2825646B1 (en) | Methods for obtaining liquid from a solid phase | |
US11905557B2 (en) | Purification chemistries and formats for Sanger DNA sequencing reactions on a micro-fluidics device | |
EP3215620B1 (en) | Chaotrope- and volatile-free method for purifying nucleic acids from plasma | |
EP2060629B1 (en) | Method of separating small RNA molecules using kosmotropic salt | |
US9434980B2 (en) | Method for concentrating sample constituents and for multiplying nucleic acids from a biological sample which are contained in the sample constituents | |
Mamaev et al. | Method for automated extraction and purification of nucleic acids and its implementation in microfluidic system | |
EP3077072B1 (en) | Extraction of circulating nucleic acids | |
US20080272053A1 (en) | Combinatorial separations and chromatography renewable microcolumn | |
RU2595374C2 (en) | Method for automated extraction with simultaneous purification of nucleic acids from several biological samples | |
US20060269929A1 (en) | Methods and kits for DNA purification on polymeric membranes at low ionic strength | |
KR20080017209A (en) | A method of isolating a dna from a microorgansim cell using a nonplanar solid substrate, a method of amplifying a nucleic acid using the isolated nucleic acid as a template and a device for isolating and amplifying a nucleic acid comprising the nonplanar solid substrate | |
KR101206039B1 (en) | A method of isolating a DNA from a microorgansim cell using a nonplanar solid substrate, a method of amplifying a nucleic acid using the isolated nucleic acid as a template and a device for isolating and amplifying a nucleic acid comprising the nonplanar solid substrate | |
CN115190913A (en) | Method for processing biological samples and device for separating cells from transport medium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: LIFE TECHNOLOGIES CORPORATION, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GOYAL, SWATI;KARGER, ACHIM;MA, PETER;AND OTHERS;SIGNING DATES FROM 20140202 TO 20140207;REEL/FRAME:039462/0266 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STCV | Information on status: appeal procedure |
Free format text: NOTICE OF APPEAL FILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |